A study from the May 2017 issue of The American Journal of Managed Care® (AJMC®) was discussed in a press release from Pennsylvania State University. In “State Prescription Drug Monitoring Programs and Fatal Drug Overdoses,” Penn State researchers found that prescription drug monitoring programs (PDMPs) were not associated with reduced mortality rates from prescription opioid overdoses. However, study co-author Yungfeng Shi, PhD, noted in the statement that the “results point to a potential unintended consequence of PDMPs, whereby reduced access to prescription drugs may have led some individuals with addictive disorders to look for alternatives.”